These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Pluta RM. Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036 [Abstract] [Full Text] [Related]
3. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Pluta RM. Acta Neurochir Suppl; 2008 Oct; 104():139-47. PubMed ID: 18456999 [Abstract] [Full Text] [Related]
5. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Jung CS, Iuliano BA, Harvey-White J, Espey MG, Oldfield EH, Pluta RM. J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672 [Abstract] [Full Text] [Related]
6. In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospasm in primates. Pluta RM, Jung CS, Harvey-White J, Whitehead A, Shilad S, Espey MG, Oldfield EH. J Neurosurg; 2005 Oct; 103(4):731-8. PubMed ID: 16266057 [Abstract] [Full Text] [Related]
7. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Jung CS, Oldfield EH, Harvey-White J, Espey MG, Zimmermann M, Seifert V, Pluta RM. J Neurosurg; 2007 Nov; 107(5):945-50. PubMed ID: 17977265 [Abstract] [Full Text] [Related]
11. A hypothesis on possible neurochemical mechanisms of action of cervical spinal cord stimulation in prevention and treatment of cerebral arterial vasospasm after aneurysmal subarachnoid hemorrhage. Yin D, Slavin KV. Med Hypotheses; 2015 Sep; 85(3):355-8. PubMed ID: 26141634 [Abstract] [Full Text] [Related]
14. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K. J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677 [Abstract] [Full Text] [Related]
15. The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage. Jung CS, Lange B, Zimmermann M, Seifert V. Neurosci Lett; 2012 Aug 22; 524(1):20-4. PubMed ID: 22796469 [Abstract] [Full Text] [Related]
16. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. Suhardja A. Nat Clin Pract Cardiovasc Med; 2004 Dec 22; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315 [Abstract] [Full Text] [Related]
17. The role of nitric oxide donors in treating cerebral vasospasm after subarachnoid hemorrhage. Fathi AR, Bakhtian KD, Pluta RM. Acta Neurochir Suppl; 2011 Dec 22; 110(Pt 1):93-7. PubMed ID: 21116922 [Abstract] [Full Text] [Related]
18. Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage. Kiriş T, Karasu A, Yavuz C, Erdem T, Unal F, Hepgül K, Baloğlu H. Acta Neurochir (Wien); 1999 Dec 22; 141(12):1323-8; discussion 1328-9. PubMed ID: 10672304 [Abstract] [Full Text] [Related]